MDRC

What MDRC does

Modern Diagnostic & Research Centre (MDRC) is an India-based diagnostic chain founded in 1984 in Gurgaon, operating 21 diagnostic centers across 8 states, 20+ laboratories, and over 1,800 sample collection points with home collection services in 20+ cities. The company offers an integrated diagnostic portfolio spanning pathology (2,500+ in-house test types including routine blood work, diabetes, lipid, thyroid profiles, infectious disease panels), radiology (Digital X-Ray, Ultrasound, ECG, Echocardiography, PFT), advanced imaging (3T MRI, CT, PET CT, SPECT, CBCT, Mammography, Bone Densitometry), and super-specialized services such as LC-MS/MS, genetic testing, tumor markers, blood cancer screening, and newborn screening. Its technology stack is anchored by NABL, NABH, and ILAC-MRA accreditations, a Digital Report Bank for online report access, and booking infrastructure via website, mobile app (iOS and Android), and WhatsApp.

MDRC serves two primary customer segments: individual patients seeking preventive checkups, condition-specific screenings, and home sample collection (the dominant revenue base), and corporate/B2B clients purchasing employee wellness and pre-employment health packages. Revenue is generated on a per-test, pay-as-you-go basis with package pricing ranging from INR 499 (basic health check) to INR 16,000 (PET CT), supplemented by imaging and home collection fees. The company monetizes through direct-to-consumer walk-ins, online/app bookings, WhatsApp-based orders, and field-based home collection. MDRC completed a Rs 37 crore pure fresh-issue IPO on the BSE SME platform in January 2026, with the issue oversubscribed over 350 times and proceeds allocated to medical equipment, working capital, and partial repayment of Rs 30.38 crore in existing borrowings. The operating model is asset-heavy (lab equipment, imaging hardware) and footprint-driven, with growth dependent on continued geographic expansion and test-volume scaling.

Name

MDRC

Legal name

Modern Diagnostic & Research Centre Pvt. Ltd.

Website

https://mdrcindia.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

501–1,000 employees

Short description

MDRC (Modern Diagnostic & Research Centre) is an India-based NABL/NABH-accredited diagnostic chain operating 21 centers, 20+ labs, and 1,800+ collection points across 8 states. It offers pathology, radiology, advanced imaging, and super-specialized testing to individual patients and corporate clients.

Ownership category

akta.pro rank

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices23 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Others

Revenue model

1. Diagnostic Testing Services: Revenue generated from pathology tests (blood tests, profiles, screenings) and radiology services (X-Ray, Ultrasound, CT Scan, MRI, Mammography). Tests range from basic screenings to comprehensive health packages.
2. Health Packages and Checkups: Pre-defined health checkup packages including full body checkups, organ-specific panels, and specialized screening packages for conditions like diabetes, thyroid, and cardiac health.
3. Home Sample Collection Services: Convenience service allowing patients to schedule blood sample collection from their home or office, with sample pickup for pathology testing.
4. IPO Proceeds: Rs 37 crore IPO with proceeds allocated for purchasing medical equipment, working capital, and partial repayment of existing borrowings of Rs 30.38 crore.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

MDRC provides integrated pathology and radiology diagnostic services through its NABL/NABH-accredited network of 21 diagnostic centres and 1,800+ collection points across 8 Indian states. Its core offering includes 2,500+ in-house pathology tests, advanced imaging (3T MRI, PET-CT, CT, Ultrasound, X-Ray, Mammography), and super-specialised services such as LC-MS/MS, genetic testing, tumour markers, and newborn screening, complemented by home sample collection and online report access.

Product overview

Modern Diagnostic & Research Centre (MDRC) is a diagnostic chain offering an integrated portfolio of pathology and radiology services across India. The company operates on a hub-and-spoke model with 21 diagnostic centers across 8 states and over 1,800 collection points. Its core offerings include in-house pathology testing (2500+ test types), radiology imaging (MRI, CT, PET-CT, Ultrasound, X-ray, Mammography, CBCT, BMD, PFT), and specialized services (genetic testing, molecular diagnostics, oncology screening). The product line is structured around comprehensive health packages (Swasthya Panel, Modern Niramaya Package series), condition-specific panels (Fever Panel, Diabetes Profile, PCOD), and advanced imaging services. Supplementary services include home sample collection in 21 cities and a digital report bank for online access. The company recently went public with an IPO on BSE SME in January 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• Pathology Laboratory Services NABL-accredited in-house pathology testing covering blood tests, diabetes profiles, lipid profiles, thyroid tests, vitamin tests, haematology, microbiology, and routine diagnostics for individual patients, referring physicians, and corporate clients.
• Radiology Imaging Services Radiology imaging services including Digital X-Ray, Ultrasound, ECG, Echocardiography, and Pulmonary Function Tests (PFT) for diagnostic imaging across MDRC's 21 centres.
• MRI Scan Services
• CT Scan Services
• PET CT Scan Services
• Swasthya Panel
• Modern Niramaya Package (1.1)
• Modern Niramaya Package (1.2)
• Modern Niramaya Package (1.3) for Woman
• Modern Niramaya Package (1.4) for Men
• Modern Fit India Package
• Home Sample Collection Service
• Digital Report Bank
• Super Specialised Services - LC-MS/MS
• Genetic Disorders Testing
• Oncology - Blood Cancers Testing
• Tumour Markers Testing
• Newborn Screening

Quantifiable outcome

• Served 1.5 crore (15 million) satisfied customers over 40+ years
• +5 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Oncquest Laboratories: Indian diagnostic chain specializing in molecular diagnostics, oncology, and genetic testing. Comparable as a provider of advanced and specialized testing serving referring physicians, patients, and hospitals.
• Neuberg Diagnostics: Pan-Indian and international diagnostics chain with focus on advanced molecular and genomic testing through partner labs. Comparable as a multi-modality provider expanding aggressively into specialized and genetic testing.
• Suburban Diagnostics: India-based diagnostic chain offering pathology and radiology services through physical centers and home-collection. Comparable as a multi-city focused Indian diagnostic operator with similar test breadth and patient-facing brand.
• Vijaya Diagnostic Centre: Indian diagnostic chain, now part of Apollo HealthCo, offering comprehensive pathology and advanced imaging services. Comparable as a regional multi-modality diagnostic operator with strong presence in North and South India.
• Dr. Lal PathLabs: India's largest organized diagnostic chain offering pathology and radiology services through a NABL-accredited network across thousands of patient service centers. Directly comparable as a multi-modality diagnostic provider with a strong North Indian base and similar enterprise/B2B2C model.
• Metropolis Healthcare: Listed Indian diagnostic chain providing comprehensive pathology and radiology testing with NABL-accredited labs across India. Comparable as a multi-modality provider serving individual patients, corporates, and referring physicians through a similar accredited network.
• Thyrocare Technologies: Indian preventive diagnostics chain specializing in cost-effective pathology testing through a hub-and-spoke model with a home-collection network. Comparable as a price-competitive preventive screening provider with similar package-led and home-collection offerings.
• SRL Diagnostics (Agilus Diagnostics): Major Indian diagnostic chain offering pathology and radiology services nationally with strong hospital B2B partnerships. Directly comparable as a multi-modality diagnostic operator with a similar accreditation portfolio and large lab network.

Regional players

• Phadke Labs: Established diagnostic chain based in Pune/Maharashtra offering pathology and radiology. Comparable as a regional Indian diagnostic operator with similar test mix, though focused on Western India rather than NCR.

Broad incumbents

• Apollo Diagnostics: Diagnostic arm of the Apollo Hospitals group with an extensive national footprint. Comparable as a large Indian diagnostic operator, though backed by the broader Apollo hospital ecosystem and overlapping portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/modernlabworld

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MDRC